Larisa is a leading neuroscientist and biochemist within UniSA Clinical and Health Sciences with expertise in stress response, diabetes and neurological disorders. Her research focuses on investigation of cellular and biochemical mechanisms of diseases, identifying novel biomarkers and testing novel treatments using animal models. She leads a number of research projects and supervises PhD and Honours students.
Larisa is also a passionate teacher. Her teaching philosophy is to provide students with the knowledge and skills that will allow them to successfully begin their professional career.
About me
Larisa is a leading neuroscientist and biochemist within UniSA Clinical and Health Sciences with expertise in stress response, diabetes and neurological disorders. Her research focuses on investigation of cellular and biochemical mechanisms of diseases, identifying novel biomarkers and testing novel treatments using animal models. She leads a number of research projects and supervises PhD and Honours students.
Larisa is also a passionate teacher. Her teaching philosophy is to provide students with the knowledge and skills that will allow them to successfully begin their professional career.
About me
About me
Doctor of Philosophy The University of Newcastle
Bachelor of Science (Honours) The Second Moscow State Medical University
Our research focuses on the following areas
1. Neurological disorders such as Alzheimer’s disease, Parkinson’s disease, depression and stroke
2. Role of Gut-Brain axis and nutrition in neurological disorders
3. Mechanisms of hypoglycaemia-associated autonomic failure in diabetes
Research
Excludes commercial-in-confidence projects.
Characterization of beta cell-like cells coverted from human urine stem cells, Channel 7 Children's Research Foundation of SA, 01/01/2018 - 31/12/2018
We are running a few stem cell research projects to produce beta pancreatic cells, liver cells and dopaminergic neurons (funded by R&D Pharma, 2017-2020)
Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2018 |
Open access
28
27
1
|
2018 |
Open access
58
53
10
|
2015 |
216
203
8
|
Year | Output |
---|---|
2022 |
3
3
2
|
2022 |
Open access
2
2
1
|
2022 |
Open access
3
2
4
|
2022 |
Open access
1
1
|
2022 |
Open access
3
|
2022 |
Open access
8
7
2
|
2022 |
Open access
552
|
2022 |
Open access
8
7
1
|
2022 |
Open access
1
1
1
|
2022 |
Open access
1
1
557
|
2021 |
Open access
4
3
11
|
2021 |
Open access
6
6
1
|
2021 |
Open access
1
1
|
2021 |
Open access
6
6
10
|
2021 |
2
1
7
|
2021 |
9
9
161
|
2021 |
Open access
5
5
|
2021 |
Open access
6
4
|
2021 |
4
5
|
2021 |
Open access
6
6
|
2021 |
Open access
3
4
5
|
2020 |
Open access
38
7
|
2020 |
6
5
|
2020 |
5
5
1
|
2020 |
6
5
1
|
2020 |
12
10
|
2020 |
8
8
3
|
2020 |
2
|
2020 |
Open access
12
12
1
|
2019 |
Open access
7
6
|
2019 |
Open access
11
10
|
2019 |
5
6
|
2019 |
Open access
13
12
7
|
2019 |
Open access
15
9
11
|
2019 |
28
23
|
2019 |
Open access
25
23
1
|
2018 |
Open access
|
2018 |
Open access
28
27
1
|
2018 |
Open access
58
53
10
|
2018 |
Open access
16
13
|
2018 |
Open access
18
|
2018 |
Open access
13
15
|
2018 |
Open access
48
44
8
|
2018 |
Open access
24
21
|
2018 |
10
10
7
|
2018 |
Open access
22
22
1
|
2018 |
8
8
|
2018 |
4
4
1
|
2018 |
36
31
55
|
2017 |
Open access
16
14
1
|
2017 |
28
30
10
|
2017 |
56
53
3
|
2017 |
Open access
|
2016 |
Open access
80
76
2
|
2016 |
21
20
|
2016 |
17
16
3
|
2016 |
Open access
12
11
|
2015 |
216
203
8
|
2015 |
27
24
|
2015 |
Open access
20
16
1
|
2014 |
Open access
26
27
4
|
2014 |
Open access
30
30
|
2013 |
17
13
|
2013 |
12
11
1
|
2012 |
Open access
30
30
|
2012 |
47
41
|
2011 |
Open access
41
39
|
2011 |
14
13
|
2011 |
Open access
20
18
|
2010 |
22
20
|
2010 |
Open access
18
17
|
2009 |
Open access
41
38
|
2009 |
36
34
|
Research
Our research focuses on the following areas
1. Neurological disorders such as Alzheimer’s disease, Parkinson’s disease, depression and stroke
2. Role of Gut-Brain axis and nutrition in neurological disorders
3. Mechanisms of hypoglycaemia-associated autonomic failure in diabetes
External engagement & recognition
Organisation | Country |
---|---|
Alexandria University | EGYPT |
China Pharmaceutical University | CHINA |
Daping Hospital | CHINA |
Flinders University | AUSTRALIA |
Hamad Bin Khalifa University | QATAR |
Kunming Medical University | CHINA |
Macquarie University | AUSTRALIA |
Medicinova | UNITED STATES |
Neuroscience Research Australia | AUSTRALIA |
New York University | UNITED STATES |
Qingdao University | CHINA |
Royal Adelaide Hospital | AUSTRALIA |
Shandong University | CHINA |
Shijiazhuang Maternity and Child Healthcare Hospital | CHINA |
Sichuan University | CHINA |
Sun Yat-Sen University | CHINA |
Third Military Medical University | CHINA |
Tianjin Medical University | CHINA |
Universidade Federal de Santa Catarina | BRAZIL |
Universidade Federal do Pampa | BRAZIL |
University of Adelaide | AUSTRALIA |
University of British Columbia | CANADA |
University of Illinois at Urbana-Champaign | UNITED STATES |
University of Melbourne | AUSTRALIA |
University of Michigan | UNITED STATES |
University of New South Wales | AUSTRALIA |
University of Newcastle | AUSTRALIA |
University of North Texas | UNITED STATES |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
University School of Medicine | UNITED STATES |
West China Hospital | CHINA |
Xiangya Hospital | CHINA |
Yunnan Mental Hospital | CHINA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
MemberAustralian Neuroscience Society |
2018 |
MemberAustralian Physiological Society |
2018 |
MemberAustralasian Society of Clinical Biochemists |
2018 |
MemberAustralian Neuroscience Society |
2017 |
MemberAustralian Physiological Society |
2017 |
MemberAustralasian Society of Clinical Biochemists |
2017 |
Member of Sansom Institute
Biochemistry, Clinical Chemistry, Molecular Pathology
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
`Neurotrophin related biomarkers in depression' | Current |
Bridging the Sex and Gender Gap in Parkinson's disease Research | Current |
Discovering the Roles of Orexins in Parkinson's disease | Current |
A role for p75 neurotrophin receptor in Neurodegeneration in Alzheimer's disease and tauopathy | Completed |
Age and comorbidity: their influence on colorectal cancer stage, treatment and survival in South Australia | Completed |
Characterisation of lipopolysaccharide models of Parkinson¿s disease, and the effects of edaravone and curcumin | Completed |
Characterization of proBDNF knock out mice and effect of proBDNF on angiogenesis | Completed |
Conversion of human urine cells and fibroblasts into neural cells with small molecules | Completed |
Functions of proBDNF and its signaling receptor p75 in neuroprotection after ischemic stroke | Completed |
Further characterisation of the rotenone model: investigation of TH and BDNF in the brain and periphery, and associated gastrointestinal dysfunction | Completed |
Hypoglycaemia-associated autonomic failure: the involvement of catecholamine producing cells in the brain and adrenal gland | Completed |
Investigation into a small molecule aided conversion of human urine cells into hepatocyte-like cells and beta-like cells in vitro | Completed |
Investigation into signalling mechanisms of BDNF in neurological disorders | Completed |
Investigation of BDNF and its precursor protein proBDNF in depression | Completed |
Investigation of therapeutic intervention for neonatal hypoxic-ischemic brain injury | Completed |
Roles of precursor of brain-derived neurotrophic factor in neuronal development and neurodegeneration | Completed |
The role of brain derived neurotrophic factor and the neurotrophin receptor p75NTR in the pathogenesis of Alzheimer¿s disease | Completed |
The role of sortilin in regulating the pathological hallmarks and behavioural symptoms in Alzheimer¿s disease | Completed |
Validation of p75ECD and edaravone as neuroprotective drug candidates for neurodegenerative diseases | Completed |